Leading pharmaceutical company in Bosnia and Herzegovina
Bosnalijek, the greatest manufacturer of drugs in Bosnia and Herzegovina, was
founded in 1951. The company has a diversified manufacturing program
encompassing 140 drugs based on 83 different generic names.
Bosnalijek manufactures a wide range of drugs for peroral, parenteral and
topical use with an effect on digestive system and metabolism, cardiovascular
system, systemic infections, skin, sceletomuscular, nervous and respiratory
system, as well as systemic hormone drugs with the exception of sex hormones.
Our strategic orientation is directed towards improving the quality of our
business and manufacturing processes. Therefore, a continuous improvement,
careful analysis and careful planning are basic principles of our operations.
Bosnalijek is continuously oriented toward its clients whose needs we monitor
and analyze with special care. The result of this commitment is a wide range of
products adapted to clients' needs.
Our business strategy is primarily based on our own human resources and
developing of a wide and competitive manufacturing range of drugs with a high
market potential. Thanks to this, Bosnalijek has become the leader on domestic
market, while almost half of its total income from sales is realized on export
Bosnalijek's orientation towards international business has resulted in high
export growth which experienced a fourfold increase over the last five years and
which has an average annual growth rate of over 30%.
The foundations of Bosnalijek's development are facility modernization, staff
training and harmonization of business with world pharmaceutical standards where
arround 118 million KM has been invested over the last 15 years.
A modern Development Center, covering an area of 1842 m2, is equipped with
modern laboratories run by top pharmaceutical experts with internationally
acquired scientific titles. We have been continuously adopting new technologies
and by having introduced the SAP IT system, we have completely automatized our
At the end of 2012, 673 people were employed in Bosnalijek out of whom 46 % were
university graduates, specialists, M.Sc.'s or Ph.D.'s.
Bosnalijek has been consistently complying with the highest world standards for
pharmaceutical industry, American and European pharmacopoeia requirements, as
well as with GMP and GLP principles .
The key foundation of Bosnalijek's success and its business policy is an
integrated management system which, along with GMP and GLP, implies quality
management 9001:2000, environmental protection 14001, as well as employees'
health and safety protection at work OHSAS 18001:1999 for which Bosnalijek was
certified in accordance with international standards. Through its responsible
behavior, Bosnalijek enhances the quality of a whole value chain in
Bosnalijek daily expresses its interest and care for development of the BIH
society by supporting various programs and manifestations in the fields of
culture, sport, science and education.
We particularly support education and have been successfully cooperating with
pharmaceutical, medical and faculties of natural sciences by sponsoring the
works of young and gifted students, as well as medical and pharmaceutical
We offer our strong support and aid to professional and scientific meetings, as
well as to the participation of BIH experts at international meetings.
Bosnalijek was awarded first prize ''Socially responsible company in BIH in
2008'' by organization Mozaik for the way the Company integrates care for the
society and environment in its activities.
Nowadays, as the leader on the BIH market, Bosnalijek places its products, many
of which are already recognizable brands, to markets in Europe and Asia. In year
2013, Bosnalijek products have been present in markets of 12 countries from
around the world.
Such a success is the result of a well-thought strategy and a totality of
efforts by Bosnalijek employees directed at developing the company into a world
known and acknowledged manufacturer.
Thanks to its business orientation with excellence as its imperative, Bosnalijek
has over the last couple of years been cooperating with world-known
pharmaceutical companies, such as Eli Lilly, Hoffman-La Roche etc.